Patent ID: 9089540
Filing Date: 2015-07-28
Classification: A61K,A61P,G01N

Abstract:
1. A method of treating colorectal cancer, comprising: (1) measuring a concentration of at least one calcium-binding protein selected from the group consisting of S100A7, S100A8, and S100A10 in a biological specimen from a subject with colorectal cancer; and (2) administering at least one anticancer agent selected from the group consisting of oxaliplatin, cisplatin, irinotecan, SN-38, and a salt thereof to the subject when the concentration of the calcium-binding protein is lower than a predetermined standard concentration for the anticancer agent, or when the concentration of the calcium binding protein does not reach a predetermined standard concentration which is set for the anticancer agent during the administration of the anticancer agent, excluding the combination of S100A10 and cisplatin.